House Foods Group (2810) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
13 Jul, 2026Executive summary
FY2024 net sales reached 315.4 billion yen, up 5.3% year-over-year, with growth in Spice/Seasoning/Processed Food, International Food, and Restaurant segments.
Operating profit rose 2.7% year-over-year to 20.0 billion yen, mainly driven by the Spice/Seasoning/Processed Food segment.
Ordinary profit increased 1.4% year-over-year to 21.4 billion yen.
Net profit dropped 28.9% year-over-year to 12.5 billion yen due to the absence of prior year gains and a 5.0 billion yen impairment loss on U.S. goodwill.
The Group advanced its global value chain and introduced ROIC as a new management indicator under its Eighth Medium-Term Business Plan.
Financial highlights
EBITDA increased to 33.9 billion yen, up 0.9 billion yen year-over-year.
Gross profit rose to 115.9 billion yen from 108.9 billion yen year-over-year.
Comprehensive income dropped 46.0% to 15.3 billion yen.
Cash and cash equivalents at year-end increased by 8.2 billion yen to 88.4 billion yen.
Dividend per share for the year was 48 yen, with a total return ratio of 84.4%.
Outlook and guidance
FY2025 net sales forecast at 333.0 billion yen (+5.6% YoY), operating profit at 21.5 billion yen (+7.5% YoY), and profit attributable to owners of parent at 13.0 billion yen (+0.5 billion yen YoY).
Annual dividend forecast maintained at 48 yen per share.
Key focus on addressing rising raw material and labor costs, especially in Spice/Seasoning/Processed Food and Restaurant businesses.
U.S. business to undergo profit structure reform and management restructuring.
The business environment is expected to remain uncertain due to global economic and cost pressures.
Latest events from House Foods Group
- Sales and operating profit rose, but net profit fell due to last year's one-time gain.2810
Q1 202513 Jul 2026 - Sales and operating profit rose, but net profit fell on one-off factors; record profit targeted.2810
Q2 202513 Jul 2026 - Sales and operating profit rose, but net profit fell on lower extraordinary gains; outlook unchanged.2810
Q3 202513 Jul 2026 - Profits fell on higher costs and weak demand, but stable dividends and a 2H recovery are forecast.2810
Q2 202613 Jul 2026 - Sales rose modestly, but profits fell sharply on higher costs; outlook and dividend unchanged.2810
Q1 202613 Jul 2026 - Sales grew modestly, but profits declined due to rising costs and inflationary pressures.2810
Q3 202613 Jul 2026 - Profits fell on higher costs and U.S. impairments, but FY2027 profit set to rebound on asset sales.2810
Q4 202613 Jul 2026